Health
Li Ka Shing Foundation, Temasek Trust jointly commit $9M to acquire systems and advance clinical trial for innovative histotripsy cancer therapy in Singapore
The Li Ka Shing Foundation (LKSF) and Temasek Trust (TT) have committed S$12 million ($8.99 million) to bring innovative non-invasive ultrasound-based histotripsy tumor clinical trials to Singapore.
The duo said in a statement on Friday that the National Cancer Centre Singapore (NCCS) and the National University Cancer Institute, Singapore (NCIS) will each receive one Histotripsy System – the first of such to be available in Southeast Asia.
The funding from LKSF and TT will also...
Temasek renews investment in global animal health firm Ceva Animal Health
Ceva Animal Health (Ceva), the world’s fifth-largest animal health company, said the Singapore-based global investment firm Temasek has renewed its investment in the company.
Ceva announced in a statement on Monday the restructuring of its capital.
According to the statement, all investors including pure investors led by Temasek, have renewed their investment, demonstrating their confidence in the company’s ability to continue its sustained growth.
It noted the long-standing...
Temasek and GIC acquire stake in Singapore-headquartered biotech specialist CRO Novotech
Novotech, Singapore-headquartered full-service biotech specialist clinical research organization (CRO), announced that affiliates of GIC and Temasek have signed binding agreements to acquire a significant stake in the company, with the additional capital earmarked to accelerate its global growth.
Existing investor TPG will also reinvest through its TPG Asia fund, Novotech said in a statement on last Sunday.
According to the statement, the reinvestment by TPG Asia and investment from GIC and...
HKUST partners SIIC to launch Hong Kong biotechnology fund
The Hong Kong University of Science and Technology (HKUST) and Shanghai Industrial Investment (Holdings) Co., Ltd. (SIIC) have announced the establishment of the Hong Kong Biotechnology Fund (HKBF) to foster innovation in the life sciences sector.
The duo said in a statement on last Thursday that with HKUST and SIIC committed as the anchor investors with a target fund size of HK$600 million ($77.2 million), at least half of the fund is dedicated for ventures associated with HKUST, including...
VNPT - VinaPhone tuyển Cộng tác viên bán hàng
VinaPhone là một trong ba nhà mạng hàng đầu tại Việt Nam. Nhằm mở rộng mạng lưới phát triển kinh doanh, đưa các dịch vụ chất lượng cao của VNPT tới mọi người, mọi nhà, VNPT VinaPhone kính mời Quý khách hàng, đối tác tham gia làm Cộng tác viên (CTV) bán hàng của chúng tôi.
Chúng tôi đang tìm kiếm những CTV bán...
Thailand’s HD HD boosts Series A to $7.8M to accelerate healthcare marketplace and AI in Southeast Asia
HD, a Thailand-based healthcare and surgery marketplace, has on Thursday announced the close of a Series A-1 strategic extension round with participation from the United States-based healthcare firm Merck Sharp & Dohme (MSD), bringing HD’s total Series A funding to $7.8 million.
HD said in a statement that with additional support from from MSD, HD is poised to expand its impact even further, making affordable, accessible healthcare a reality across Southeast Asia.
By 2025, the...
Life Science Incubator unveils Singapore’s largest co-working laboratory at Elementum
Life Science Incubator (LSI) has officially launched the largest co-working laboratory in Singapore at Elementum, located in JTC’s one-north business park.
This launch further strengthens Singapore’s prominence as a premier life sciences hub in Asia Pacific, LSI said in a statement on Monday.
As Singapore continues to be a preferred destination for biotech, MedTech, and pharmaceutical innovation, LSI opined that the demand for high-quality laboratory space remains high.
It said...
How data analytics and business intelligence are driving discovery and innovation in healthcare
Innovation in the healthcare industry is not a choice but a need to generate cost-effective solutions and better patient outcomes. The balance of data analytics and business intelligence with due diligence spurs potential areas of discovery, optimizes regular operations, and elevates healthcare quality. Business intelligence in healthcare involves collecting and processing extensive data from diverse sources such as digital health records, medi-claim documents, history of treatments,...
Using Gen AI in healthcare puts lives on the line – here’s how to mitigate this
As the use of Gen AI tools in the workplace continues to proliferate and starts becoming a staple much like the document software that we use every day, it follows that many end users trust it to deliver faultless answers. Unfortunately, this assumption does not hold true as recent studies have revealed that Gen AI models often provide answers that are less accurate than its confidence level suggests.
This mismatch between this level of accuracy and the projected confidence of Gen AI tools...
Accelerating new drug development with AI in APAC
Clinical trials are becoming increasingly complex highlighting the need for efficiency. At the same time, electronic storage and computing power have increased dramatically and there are more opportunities for data sharing across industry stakeholders as patient data awareness is increasing. With these conditions, AI is poised to make scientific decisions easier and more reliable, therefore, making new drug development more efficient.
The clinical trial landscape in Asia Pacific
Over the...
Ant Group to connect 280,000 doctors on Haodf healthcare platform with 800M healthcare users on Alipay after acquisition
Following Ant Group’s acquisition of Haodf, a healthcare platform specializing in online doctor consultations, Ant Group President Cyril Han and Haodf.com Founder Hang Wang have jointly announced their plans to drive AI-powered healthcare innovations.
Ant Group said in a statement on last Saturday that these efforts aim to help 280,000 doctors on the Haodf platform work more efficiently and better serve 800 million healthcare users on the Alipay super app.
At Haodf.com’s annual...
Singapore’s August Global Partners invests in Vietnam’s Gene Solutions
Singapore-headquartered healthcare investor August Global Partners (AGP) is investing in Vietnam=based genomic testing company Gene Solutions (GS) through a proprietary funding round.
Gene Solutions said in a statement that the duo have signed a memorandum of understanding (MoU) for the partnership.
Under the MoU, GS will support broader adoption of precision medicine and targeted therapeutics in Asia through the development of a suite of artificial intelligence (AI) technologies that...
More Blogs
Sponsored
Read More
Singapore’s Elev8 Venture Partners leads $50M funding round in smallcase
Smallcase, India’s largest model portfolios platform, has raised $50 million in its Series...
Bosideng’s luxury pivot: Can Moose Knuckles elevate its outdoor game?
Partnering with the Canadian luxury brand could bolster Bosideng’s entry into high-end...
Điện thoại Realme Note 60x 3GB/64GB 2.390.000₫
realme Note 60x ghi dấu ấn với thiết kế vuông vức đầy mạnh mẽ, đi kèm các...
TrueMoney Malaysia launches international remittance services for businesses and e-wallet users to send money overseas
TrueMoney Malaysia, part of the region-leading Ascend Money financial platform, has on Tuesday...
VNPT ra mắt gói cước Internet tốc độ tối thiểu 300Mbps
Từ 1/4/2025, tất cả các gói cước Internet mới của VNPT sẽ được cung cấp với tốc độ...